Skip to main content
Clinical Trials/EUCTR2010-018737-21-IT
EUCTR2010-018737-21-ITActive, not recruitingNot Applicable

Safety and efficacy of treatment with propranolol in newborns suffering from rethinopathy of the preterm: a pilot study - Propranolol and ROP

AZIENDA OSPEDALIERA MEYER0 sitesStarted: April 7, 2010Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Newborns with gestational age 23-32 weeks with ROP Stadium 2 Zone II-III without plus
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • Generals: congenital cardiovascolar anormalities, renal failure, cerebral hemorrhages.
  • Local: ROP of stadium higher than II

Investigators

Sponsor
AZIENDA OSPEDALIERA MEYER

Similar Trials